Abstract:Background Dilated cardiomyopathy (DCM) is a primary heart muscle disease characterised by left-ventricular dilatation and reduced contractility, often associated with arrhythmia and conduction disease. DCM often has a genetic component, putting family members of diagnosed patients at risk for the disease. Stratification tools to provide personalized screening advice are currently lacking. Artificial intelligence (AI) based analysis of the electrocardiogram (ECG) offers a potential solution to this challenge. Purpose Our study aims to develop and validate a novel AI-ECG model capable of prediction and early detection of DCM. Methods An AI-ECG model was developed on a United States (US) based secondary care centre dataset including 337,463 ECGs from 50,932 patients within 4 months of diagnostic echocardiography and 265,576 ECGs from 51,086 patients prior to the first diagnostic echo. The data was split 50/10/40% for training, validation, and testing, with each subset containing 9-12% DCM positive labels. The model architecture was based on a convolutional neural network with residual blocks with a modified final layer for a discrete-time survival model. The AI-ECG score was linked to changes in the median ECG within the test set to provide explainability. External validation was performed on 68,885 diagnostic ECGs (0.08% DCM positive) from the UK biobank (UKB) and a Chinese general hospital dataset with 317,854 diagnostic ECGs (2.2% DCM positive) and 76,936 predictive ECGs (1.7% DCM positive). We performed common and rare variant association studies for the AI ECG scores on quality-controlled UKB data. Results The AI-ECG score for predicted future DCM was associated with diverse ECG features (Fig. 1). In the US cohort test set, the model achieved high diagnostic accuracy with an AUC of 0.9 (95% CI 0.89-0.90) overall, and 0.89 (0.85-0.92) in a subset excluding ischemic or valvular heart disease. External datasets showed AUCs of 0.86 (0.81-0.91) in the UKB and 0.97 (96-0.97) in the Chinese dataset. The predictive performance of the AI-ECG score, adjusted for age and sex, closely approximated echocardiographic traits (LVEF and LVEDD, Fig. 2) with a concordance index (CI) of 0.79 (0.76-0.83) and 0.81 (0.77-0.85), respectively, at 10 years of follow up (FU). Combining AI-ECG scores with echocardiographic traits enhanced the CI to 0.84 (0.8-0.87). Similar findings were observed in the Chinese dataset, with a CI of 0.87 (0.85-0.89) for the AI-ECG score and 0.9 (0.88-0.92) for echocardiographic traits. Genetic analyses in UKB identified associations between the AI-ECG score and rare TTN variants as well as 25 common variant loci. Conclusion Our explainable AI ECG model for future DCM prediction demonstrates robust performance across datasets, providing comparable predictive accuracy to echocardiographic traits up to 10 years pre-diagnosis. Genetic associations support the model's validity and provide new tools for DCM genetic discovery.

Deep Learning-Derived 12-Lead Electrocardiogram-Based Genotype Prediction for Hypertrophic Cardiomyopathy: a Pilot Study.

Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Machine learning can identify hypertrophic cardiomyopathy in pediatric patients using electrocardiogram

Identification of High-Risk Imaging Features in Hypertrophic Cardiomyopathy using Electrocardiography: A Deep-Learning Approach

Identification of Hypertrophic Cardiomyopathy on Electrocardiographic Images with Deep Learning

Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram

Enhancement of the Mayo Clinic Genotype Predictor Score using Cardiac MRI

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy

Diagnosis of hypertrophic cardiomyopathy by artificial intelligence using standard transthoracic echocardiography

Abstract 9715: Feasibility of Using Machine Learning to Establish a Risk Prediction Model for Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy

Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features

Abstract 14817: Machine Learning Computer Vision for Point of Care Decision Support of Echocardiographic Identification of Hypertrophic Cardiomyopathy

Accurate detection of dilated cardiomyopathy onset through machine learning predictions from ECG data

Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study

Machine Learning in Hypertrophic Cardiomyopathy: Nonlinear Model From Clinical and CMR Features Predicting Cardiovascular Events

A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods

Evaluating convolutional neural network-enhanced electrocardiography for hypertrophic cardiomyopathy detection in a specialized cardiovascular setting

Electrocardiogram-based deep learning to predict mortality in paediatric and adult congenital heart disease

Deep Learning-Augmented ECG Analysis for Screening and Genotype Prediction of Congenital Long QT Syndrome

Deep learning of echocardiography distinguishes between presence and absence of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy